The AD/PD™ 2022 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders took place in Barcelona, Spain and online on March 15-20, 2022.
At the meeting, Johan Pihl, COO at Cellectricon, presented poster P480 / #889 on:
“An in vitro alpha-synuclein aggregation assay in primary cortical cultures suitable for pharmacological characterization, target discovery and validation”
To receive a copy of the poster and to learn more about Cellectricon’s services for neurodegenerative disease drug discovery we invite you to reach out to us.
Want to learn more?
If you would like to learn more about Cellectricon’s drug discovery services for pain and neurodegenerative disease research, you are very welcome to reach out and schedule a meeting with us.